Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

BetterMe Rx vs Recovery Delivered

Two GLP-1 desks, one scoreboard. We put BetterMe Rx and Recovery Delivered head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 25 · Grade B

BetterMe Rx

Visit BetterMe Rx Full brief →
vs
No. 134 · Grade C

Recovery Delivered

Visit Recovery Delivered Full brief →

The verdict

BetterMe Rx takes this head-to-head.

BetterMe Rx scores 85 to 71 on our six-factor Brief Score — A LegitScript-certified, app-adjacent program with an oral option and mid-market pricing nationwide.

That doesn't make Recovery Delivered a bad call — it's best for readers who want cheap compounded glp-1 with an included provider video visit and fast home delivery. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
48
Supply Reliability
85
71
Transparency
86
88
Access Breadth
90
80
Clinical Oversight
86
76
Track Record
80
69
BetterMe RxBrief Score 85 · 71Recovery Delivered

Price, coverage & the tracker

BetterMe RxRecovery Delivered
Brief Score85/100 (B)71/100 (C)
Semaglutide$199/moFrom $199/mo (starting dose, compounded)
Tirzepatide$299/moFrom $219/mo (2.5 mg dose, compounded)
CoverageAll 50 states32 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

BetterMe Rx: $199 sema / $299 tirz held at the mid-market line; LegitScript-certified.

Recovery Delivered: New to the tracker on 1 August 2026. The published line reads From $199/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.